Calprotectina fecal como marcador diferencial entre patología gastrointestinal orgánica y funcional

[1]  M. G. Sánchez,et al.  Precisión diagnóstica de la calprotectina fecal para predecir una colonoscopia patológica , 2006 .

[2]  A. M. Caballero,et al.  La gammagrafía con leucocitos marcados con 99mTc-HMPAO en el diagnóstico y seguimiento de la enfermedad inflamatoria intestinal , 2006 .

[3]  P. Delgado,et al.  Diagnostic yield of 335 push video-enteroscopies , 2006 .

[4]  A. Sodano,et al.  Combined Use of Noninvasive Tests is Useful in the Initial Diagnostic Approach to a Child with Suspected Inflammatory Bowel Disease , 2006, Journal of pediatric gastroenterology and nutrition.

[5]  L. Hansson,et al.  Colorectal Inflammation is Well Predicted by Fecal Calprotectin in Children with Gastrointestinal Symptoms , 2005, Journal of pediatric gastroenterology and nutrition.

[6]  W. Sandborn,et al.  Predicting relapse in patients with inflammatory bowel disease: what is the role of biomarkers? , 2005, Gut.

[7]  H. Hanai,et al.  Relationship Between Fecal Calprotectin, Intestinal Inflammation, and Peripheral Blood Neutrophils in Patients with Active Ulcerative Colitis , 2004, Digestive Diseases and Sciences.

[8]  L. Barbot,et al.  High faecal calprotectin concentrations in newborn infants , 2004, Archives of Disease in Childhood - Fetal and Neonatal Edition.

[9]  R. Badolato,et al.  New Insights into the Biology of the Acute Phase Response , 1999, Journal of Clinical Immunology.

[10]  L. Hansson,et al.  Fecal Calprotectin Levels in Healthy Children Studied With an Improved Assay , 2003, Journal of pediatric gastroenterology and nutrition.

[11]  G. Di Fede,et al.  Diagnostic accuracy of fecal calprotectin assay in distinguishing organic causes of chronic diarrhea from irritable bowel syndrome: a prospective study in adults and children. , 2003, Clinical chemistry.

[12]  I. Forgacs,et al.  Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. , 2002, Gastroenterology.

[13]  D. Shreeve,et al.  Faecal calprotectin: a marker of inflammation throughout the intestinal tract , 2002, European journal of gastroenterology & hepatology.

[14]  A. Berstad,et al.  Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children , 2002, Acta paediatrica.

[15]  I. Bjarnason,et al.  Non-invasive investigation of inflammatory bowel disease. , 2001, World journal of gastroenterology.

[16]  M. Fagerhol.  Calprotectin, a faecal marker of organic gastrointestinal abnormality , 2000, The Lancet.

[17]  I. Bjarnason,et al.  Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. , 2000, Gastroenterology.

[18]  H. Schjønsby,et al.  Improved assay for fecal calprotectin. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[19]  A. Staiano,et al.  Childhood functional gastrointestinal disorders , 1999, Gut.

[20]  A. Røseth,et al.  Correlation between faecal excretion of indium-111-labelled granulocytes and calprotectin, a granulocyte marker protein, in patients with inflammatory bowel disease. , 1999, Scandinavian journal of gastroenterology.

[21]  M. Fagerhol.  Nomenclature for proteins: is calprotectin a proper name for the elusive myelomonocytic protein? , 1996, Clinical molecular pathology.

[22]  A. Røseth,et al.  Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. , 1992, Scandinavian journal of gastroenterology.

[23]  P. Brandtzaeg,et al.  Distribution of a new myelomonocytic antigen (L1) in human peripheral blood leukocytes. Immunofluorescence and immunoperoxidase staining features in comparison with lysozyme and lactoferrin. , 1985, American journal of clinical pathology.